Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Nuclear Medicine/Radiopharmaceuticals Market Size Analysis from 2022 to 2027
1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Nuclear Medicine/Radiopharmaceuticals Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Nuclear Medicine/Radiopharmaceuticals Industry Impact
Chapter 2 Global Nuclear Medicine/Radiopharmaceuticals Competition by Types, Applications, and Top Regions and Countries
2.1 Global Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Type
2.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Type (2016-2021)
2.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Type (2016-2021)
2.2 Global Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Application
2.2.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Application (2016-2021)
2.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Application (2016-2021)
2.3 Global Nuclear Medicine/Radiopharmaceuticals (Volume and Value) by Regions
2.3.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption by Regions (2016-2021)
4.2 North America Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
4.10 South America Nuclear Medicine/Radiopharmaceuticals Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Nuclear Medicine/Radiopharmaceuticals Market Analysis
5.1 North America Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
5.1.1 North America Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
5.2 North America Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
5.3 North America Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
5.4 North America Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
5.4.1 United States Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
5.4.2 Canada Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
5.4.3 Mexico Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 6 East Asia Nuclear Medicine/Radiopharmaceuticals Market Analysis
6.1 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
6.1.1 East Asia Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
6.2 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
6.3 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
6.4 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
6.4.1 China Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
6.4.2 Japan Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
6.4.3 South Korea Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 7 Europe Nuclear Medicine/Radiopharmaceuticals Market Analysis
7.1 Europe Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
7.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
7.2 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
7.3 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
7.4 Europe Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
7.4.1 Germany Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.2 UK Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.3 France Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.4 Italy Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.5 Russia Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.6 Spain Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.7 Netherlands Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.8 Switzerland Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
7.4.9 Poland Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 8 South Asia Nuclear Medicine/Radiopharmaceuticals Market Analysis
8.1 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
8.1.1 South Asia Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
8.2 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
8.3 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
8.4 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
8.4.1 India Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
8.4.2 Pakistan Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Analysis
9.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
9.1.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
9.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
9.3 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
9.4 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
9.4.1 Indonesia Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.2 Thailand Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.3 Singapore Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.4 Malaysia Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.5 Philippines Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.6 Vietnam Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
9.4.7 Myanmar Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 10 Middle East Nuclear Medicine/Radiopharmaceuticals Market Analysis
10.1 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
10.1.1 Middle East Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
10.2 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
10.3 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
10.4 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
10.4.1 Turkey Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.3 Iran Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.5 Israel Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.6 Iraq Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.7 Qatar Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.8 Kuwait Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
10.4.9 Oman Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 11 Africa Nuclear Medicine/Radiopharmaceuticals Market Analysis
11.1 Africa Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
11.1.1 Africa Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
11.2 Africa Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
11.3 Africa Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
11.4 Africa Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
11.4.1 Nigeria Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.2 South Africa Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.3 Egypt Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.4 Algeria Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
11.4.5 Morocco Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 12 Oceania Nuclear Medicine/Radiopharmaceuticals Market Analysis
12.1 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
12.2 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
12.3 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
12.4 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption by Top Countries
12.4.1 Australia Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
12.4.2 New Zealand Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 13 South America Nuclear Medicine/Radiopharmaceuticals Market Analysis
13.1 South America Nuclear Medicine/Radiopharmaceuticals Consumption and Value Analysis
13.1.1 South America Nuclear Medicine/Radiopharmaceuticals Market Under COVID-19
13.2 South America Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Types
13.3 South America Nuclear Medicine/Radiopharmaceuticals Consumption Structure by Application
13.4 South America Nuclear Medicine/Radiopharmaceuticals Consumption Volume by Major Countries
13.4.1 Brazil Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.2 Argentina Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.3 Columbia Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.4 Chile Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.5 Venezuela Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.6 Peru Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
13.4.8 Ecuador Nuclear Medicine/Radiopharmaceuticals Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceuticals Business
14.1 China Isotope & Radiation
14.1.1 China Isotope & Radiation Company Profile
14.1.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product Specification
14.1.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Ciaeriar
14.2.1 Ciaeriar Company Profile
14.2.2 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product Specification
14.2.3 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Dongcheng
14.3.1 Dongcheng Company Profile
14.3.2 Dongcheng Nuclear Medicine/Radiopharmaceuticals Product Specification
14.3.3 Dongcheng Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Jaco
14.4.1 Jaco Company Profile
14.4.2 Jaco Nuclear Medicine/Radiopharmaceuticals Product Specification
14.4.3 Jaco Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Shanghai Atom Kexing
14.5.1 Shanghai Atom Kexing Company Profile
14.5.2 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product Specification
14.5.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Advanced Molecular-imaging Solution
14.6.1 Advanced Molecular-imaging Solution Company Profile
14.6.2 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product Specification
14.6.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Nuclear Medicine/Radiopharmaceuticals Market Forecast (2022-2027)
15.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Nuclear Medicine/Radiopharmaceuticals Value and Growth Rate Forecast (2022-2027)
15.2 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Nuclear Medicine/Radiopharmaceuticals Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption Forecast by Type (2022-2027)
15.3.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
15.3.3 Global Nuclear Medicine/Radiopharmaceuticals Price Forecast by Type (2022-2027)
15.4 Global Nuclear Medicine/Radiopharmaceuticals Consumption Volume Forecast by Application (2022-2027)
15.5 Nuclear Medicine/Radiopharmaceuticals Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
